TNB
EW icon

Thomasville National Bank’s Edwards Lifesciences EW Stock Holding History

Thomasville National Bank’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-5,595
Closed -$204K – 210
2017
Q3 		$204K Buy
5,595
+417
+8% +$15.9K 0.03% 249
2017
Q2 		$204K Buy
+5,178
New +$189K 0.04% 242

Other funds holding EW

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Thomasville National Bank's EW Position: Q4 2017 in Review

Thomasville National Bank sold out of Edwards Lifesciences (EW) in Q4 2017, closing a stake of 5,595 shares — an estimated $204K sold.

Thomasville National Bank first reported a position in EW in Q2 2017 and held it in 2 quarters. The position peaked at $204K in Q3 2017. 773 funds tracked by Wall St. Rank hold EW as of Q4 2017.

  • Thomasville National Bank reported no remaining Edwards Lifesciences position as of Q4 2017 after selling out during the quarter.
  • Thomasville National Bank sold 5,595 Edwards Lifesciences shares in Q4 2017, an estimated $204K.
  • Thomasville National Bank first reported a position in Edwards Lifesciences in Q2 2017 and held it in 2 quarters.
  • Thomasville National Bank's Edwards Lifesciences position peaked at $204K in Q3 2017.
  • 773 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q4 2017.

Based on Thomasville National Bank's 13F filing for Q4 2017, filed 5 Feb 2018.